BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35843139)

  • 1. Multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in rats.
    Bongiovanni AR; Zhao P; Inan S; Wiah S; Shekarabi A; Farkas DJ; Watson MN; Wimmer ME; Ruff MR; Rawls SM
    Drug Alcohol Depend; 2022 Sep; 238():109556. PubMed ID: 35843139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine receptor antagonists enhance morphine's antinociceptive effect but not respiratory depression.
    Inan S; Chen X; Eisenstein EM; Meissler JJ; Geller EB; Tallarida C; Watson M; Doura M; Barrett JE; Cowan A; Rawls SM; Adler MW; Eisenstein TK
    Life Sci; 2021 Nov; 285():120014. PubMed ID: 34619167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of morphine antinociception and inhibition of diabetic neuropathic pain by the multi-chemokine receptor antagonist peptide RAP-103.
    Ruff MR; Inan S; Shi XQ; Meissler JJ; Adler MW; Eisenstein TK; Zhang J
    Life Sci; 2022 Oct; 306():120788. PubMed ID: 35817166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
    Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
    Front Immunol; 2020; 11():615327. PubMed ID: 33408720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Selective Lesions of Nucleus Accumbens µ-Opioid Receptor-Expressing Cells on Heroin Self-Administration in Male and Female Rats: A Study with Novel
    Bossert JM; Mejias-Aponte CA; Saunders T; Altidor L; Emery M; Fredriksson I; Batista A; Claypool SM; Caldwell KE; Reiner DJ; Chow JJ; Foltz M; Kumar V; Seasholtz A; Hughes E; Filipiak W; Harvey BK; Richie CT; Vautier F; Gomez JL; Michaelides M; Kieffer BL; Watson SJ; Akil H; Shaham Y
    J Neurosci; 2023 Mar; 43(10):1692-1713. PubMed ID: 36717230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. μ-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice.
    Wiskerke J; Schetters D; van Es IE; van Mourik Y; den Hollander BR; Schoffelmeer AN; Pattij T
    J Neurosci; 2011 Jan; 31(1):262-72. PubMed ID: 21209211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular administration of CYX-6, a potent μ-opioid receptor agonist, a δ- and κ-opioid receptor antagonist and a biased ligand at μ, δ & κ-opioid receptors, evokes antinociception with minimal constipation and respiratory depression in rats in contrast to morphine.
    Imam MZ; Kuo A; Ghassabian S; Cai Y; Qin Y; Li T; Smith MT
    Eur J Pharmacol; 2020 Mar; 871():172918. PubMed ID: 31958457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.
    Miner P; Shimonova L; Khaimov A; Borukhova Y; Ilyayeva E; Ranaldi R; Bodnar RJ
    Brain Res; 2012 Mar; 1443():34-51. PubMed ID: 22305145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats.
    Xiong W; Yu LC
    Neurosci Lett; 2006 May; 399(1-2):167-70. PubMed ID: 16490317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine Receptor Antagonists in Combination with Morphine as a Novel Strategy for Opioid Dose Reduction in Pain Management.
    Eisenstein TK; Chen X; Inan S; Meissler JJ; Tallarida CS; Geller EB; Rawls SM; Cowan A; Adler MW
    Mil Med; 2020 Jan; 185(Suppl 1):130-135. PubMed ID: 32074321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. μ-opioid receptors in the stimulation of mesolimbic dopamine activity by ethanol and morphine in Long-Evans rats: a delayed effect of ethanol.
    Valenta JP; Job MO; Mangieri RA; Schier CJ; Howard EC; Gonzales RA
    Psychopharmacology (Berl); 2013 Aug; 228(3):389-400. PubMed ID: 23503684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal.
    Lewanowitsch T; Irvine RJ
    Eur J Pharmacol; 2002 Jun; 445(1-2):61-7. PubMed ID: 12065195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat.
    Turchan J; Przewłocka B; Toth G; Lasoń W; Borsodi A; Przewłocki R
    Neuroscience; 1999; 91(3):971-7. PubMed ID: 10391475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coadministration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats.
    Inan S; Eisenstein TK; Watson MN; Doura M; Meissler JJ; Tallarida CS; Chen X; Geller EB; Rawls SM; Cowan A; Adler MW
    J Pharmacol Exp Ther; 2018 Dec; 367(3):433-441. PubMed ID: 30249618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation.
    Padi SSV; Shi XQ; Zhao YQ; Ruff MR; Baichoo N; Pert CB; Zhang J
    Pain; 2012 Jan; 153(1):95-106. PubMed ID: 22033364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute morphine administration alters the power of local field potentials in mesolimbic pathway of freely moving rats: Involvement of dopamine receptors.
    Ahmadi Soleimani SM; Mohamadi M A H MH; Raoufy MR; Azizi H; Nasehi M; Zarrindast MR
    Neurosci Lett; 2018 Nov; 686():168-174. PubMed ID: 30219483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src family kinases involved in CXCL12-induced loss of acute morphine analgesia.
    Rivat C; Sebaihi S; Van Steenwinckel J; Fouquet S; Kitabgi P; Pohl M; Melik Parsadaniantz S; Reaux-Le Goazigo A
    Brain Behav Immun; 2014 May; 38():38-52. PubMed ID: 24263070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain.
    Szabo I; Chen XH; Xin L; Adler MW; Howard OM; Oppenheim JJ; Rogers TJ
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10276-81. PubMed ID: 12130663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.